Award
Delivery Order #SPE2D326F7349
Delivery Order for Mucinex Tablets Under Long-Term Pharmaceutical IDIQ Contract
Buyer
Defense Logistics Agency
Award Amount
$36.70
Ceiling
$36.70
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2D326F7349
NAICS
325411
This award is a delivery order contract placed with DMS Pharmaceutical Group Inc, a specialized pharmaceutical manufacturer and distributor, operating under a larger multi-year Indefinite Delivery Indefinite Quantity (IDIQ) agreement. The specific procurement focuses on the supply of Mucinex D ER 600-60 mg tablets, a combination medication used for respiratory relief. The delivery order supports the broader pharmaceutical manufacturing services that DMS provides, ensuring the availability of essential medications within the government supply chain. This order is significant for maintaining ongoing medical readiness by fulfilling short-term needs under a flexible long-term contract structure. The scope of work involves the timely manufacturing and delivery of the specified medication within a three-day period, highlighting efficient procurement and supply capabilities. While competitive bidding details for this order are not specified, the parent IDIQ contract suggests a mechanism that balances competitive and flexible ordering. The contract's timeline is notably short and targeted, reflecting prompt responsiveness to specific pharmaceutical demands. The underlying IDIQ contract framework secured between early 2021 and 2031 provides a robust foundation for these delivery orders, supporting sustained government pharmaceutical requirements.
Description
4571056028!MUCINEX D ER 600-60 MG TABLET 18S